Thank you, Rich. As Michael mentioned, our intention with the increased flexibility afforded by the modified asset coverage requirement is to expand our portfolio through investments in our three core strategies. Firstly in senior secured cash flow loans to upper mid-market companies; first lien asset based loans secured predominantly by accounts receivable to mid-sized companies that operate exclusively in the healthcare industry through our company Gemino; and lastly, first lien asset-based loans and factoring facilities secured by accounts receivable to mid-sized companies that operate predominantly in manufacturing services and distribution industries. In addition, we will continue to evaluate opportunities to further expand our specialty financed platform. In the aggregate, at quarter end, our investments across these three segments totaled approximately $625 million encompassing 170 distinct issuers. The average investment per issuer was approximately $3.7 million or 0.6% of the comprehensive portfolio, highly diversified. When measured at their value, approximately 98% of our portfolio consisted of senior secured loans, of which over 57% are in first lien cash flow loans, 40% are in first lien asset-based loans, and only 2% are in second lien cash flow loans with a dominium's amount in equity, less than 1%. In addition, over 90% of our investments have floating rate coupons which should continue to benefit our performance in today's rising rate environment. SUNS' weighted average yield on a fair value basis for it's total portfolio was 9.6%, consistent with the prior quarter. Including investments and repayments across our three lines of business, originations totaled $40 million and repayments were approximately $125 million; this resulted in a reduction of $86 million in our overall portfolio. As Michael mentioned, we experienced elevated repayments in our cash flow portfolio and elected not to reinvest in the new structures on the basis of terms and capital structure that did not meet our current underwriting requirements. Now, let me provide an update on the credit quality and earnings power of the portfolio. At quarter end, 100% of our portfolio is performing. Our internal risk assessment on a weighted average of our loan portfolio remains at two at 930, and based on our one to four risk-rating scale with one representing the least amount of risk. Today, our watch list represents less than 5% of our overall portfolio. Now, let me touch on our three investment verticals. Cash flow; at quarter end, our portfolio totaled $370 million of cash flow loans representing 60% of the total portfolio. Our cash flow portfolios comprised of loans to 50 different borrowers with an average investment size of $7.5 million. The fair value weighted average asset level yield at this portfolio was just under 8%, up slightly from the prior quarter. Our second lien cash flow exposure represents only 2% of the entire $600 million portfolio and we expect this to continue to climb over the coming quarters. At September 30, the weighted average EBITDA of our first lien cash flow investments was $98 million, clearly upper end of mid-market. On a fair value weighted average basis, leverage through our investment was 4.4 times, and interest coverage ratio was 2.6 times, representing a lower risk profile than the liquid loan market. In addition, the weighted average latest 12 months revenue growth was over 8% and EBITDA growth was approximately 7%, reflecting continued positive trends in our portfolio company fundamentals. During the third quarter, we originated cash flow investments of $30 million and had repayments of approximately $95 million. With the addition of the newly raised private capital, SUNS is already benefiting from SCPs increased scale and ability to be a full-solutions provider. For example, recently we were able to support every [ph] partner's refinancing of AEGIS [ph] toxicology sciences, previously a portfolio company of our sister BDC-SORC. As a platform, we doubled our investment dollars to over $65 million across our platform with SUNS taking an $11 million investment in the first lien term loan. Let me turn to North Mill. At quarter end, our North Mill portfolio was approximately $146 million, representing over 23% of our total portfolio. This portfolio includes loans to 87 distinct bars with an average funded investment size of $1.7 million. The weighted average asset yield at North Mill was 12.7%. During the quarter, we have an increase of $1 million of funding's and repayments of $18 million. For the quarter, North Mill paid SUNS a cash dividend of $0.4 million equating to a 10.2% average annual yield on cross. Now turning to Gemino. At quarter end, Gemino's portfolio was $108 million, representing 17% of our comprehensive portfolio. Gemino's portfolio was comprised of loans of 33 borrowers with an average funded loan size of $3.3 million. The weighted average asset level yield for Gemino's portfolio was 11.4%. During the quarter, we funded $10 million of new asset-based investments and had repayments of approximately $13 million. For the quarter, Gemino paid SUNS a dividend of just under $1 million, equating to an 11% annualized yielded cost. In summary, as Michael mentioned, the middle market cash flow lending environment remains extremely frothy. At SUNS, we benefit from our diversified origination engines across both cash flow and asset-based lending verticals, which allows us to allocate capital to those investments that meet our strict underwriting criteria. In addition, we believe the enhancement to the investment budget platform scale will result in more investment opportunities across both, our cash flow and specialty finance asset classes at SUNS. However, we will continue to be prudent and highly disciplined in deploying our substantial available capital. Now, let me turn the call back to Michael.